NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 28th, 2014

ACC.14 Headquarters

wpengine

CardioExchange is dedicated to bringing you the latest from ACC.14. Check out our coverage of the conference ─ and some of the great debates these posts have sparked ─ then tell us what you think!

News:

  • No Benefit Found in First Real Test of Renal Denervation
  • Survival Advantage for TAVR Over Surgery in High-Risk Patients
  • First TAVR Comparison Trial Favors Sapien XT Over CoreValve
  • MADIT-CRT Long-Term Follow-Up Shows Survival Benefit with CRT-D
  • High-Sensitivity Troponin Test Could Identify Low-Risk Chest Pain Patients in the ED
  • Aspirin and Clonidine Fail to Help Surgery Patients
  • Novartis Trial Was Stopped Early Because of a Significant Drop in Cardiovascular Mortality

Analysis:

  • Negative Findings on Renal Denervation for Hypertension: Sweet SYMPLICITY?
  • TAVR: Are You Impressed Now?
  • Long-Term Follow-Up from MADIT-CRT: Guideline Implications
  • Are We Equipped to Make a CHOICE Between TAVR Devices?

Follow our Fellows:

  • Changing My Priorities for ACC.14
  • Ideals Lost, But Not Stolen
  • Are Digital Conferences the Way of the Future?
  • Taking Patient-Centerdness to the Next Level at ACC.14
  • Stage Set for Phase IV Trials of PCSK9 Inhibition
  • Master of all Trades

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Celiac-Artery Dissection September 12, 2026
      A 72-year-old man with hypertension, hyperlipidemia, and a stable ascending aortic aneurysm presented with sudden-onset, severe chest pain. CTA of the chest, abdomen, and pelvis showed a celiac-artery dissection.
    • Complete Revascularization Guided by Functional Coronary Angiography in STEMI September 10, 2026
      Among patients with ST-segment elevation myocardial infarction and multivessel disease, physiology-guided angiography led to a lower risk of major cardiovascular events than conventional angiography-guided treatment.
    • Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials September 9, 2026
      In two placebo-controlled trials, oveporexton improved wakefulness, reduced daytime sleepiness, and lowered the cataplexy rate among patients with narcolepsy type 1. Increased urinary frequency and transient insomnia were common.
    • Immediate Ambulatory Electrocardiographic Monitoring in Syncope August 31, 2026
      Among patients with syncope that remained unexplained after evaluation in the ED, immediate initiation of 14-day ECG monitoring did not result in significantly fewer patient-reported syncope episodes at 1 year than standard care.
    • Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism August 31, 2026
      Catheter-directed thrombolysis led to a lower risk of death, recurrent pulmonary embolism, or cardiorespiratory decompensation or collapse at 7 days than anticoagulation alone in intermediate-high–risk acute pulmonary embolism.
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |